Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
What should marketing and medical affairs invest in for Q4?
Join Jade and Isabel as they explore the critical trends that have shaped the industry in 2024 and what teams should leverage in Q4.
Read more
Super reps, ChatGPT and pharma’s future on social media
Isabel chats to Darshan Kulkarni, regulatory and compliance attorney for the Life Sciences, about key marketing and medical affairs trends.
Meet GOLD's new catalyst – AZ’s Mina Makar
Helena and Isabel share exclusive clips from the conversation with GOLD’s latest Catalyst interviewee: AstraZeneca’s Mina Makar.
New era for neuroscience and the importance of purpose
Helena and Isabel kick off Season 4 with Janssen’s Kavita Panke, talking all things neuroscience, high performing teams and more!
The 2023 pharma forecast
Join Helena and Isabel in ringing in the 2023 with a special predictions episode. What’s in store for pharma this year?
Pharma review of the year 2022
Helena and Isabel are joined by six guests to round off 2022 and Season 3 with a look back at the key highlights of the past 12 months.
Sales reps, MSLs and the future of CX
In this episode, the team chat to James Harper, Founder and Managing Director, Twentyeightb, about pharma sales, MSLs and more.
Meet GOLD's new catalyst – GSK's John Wahba
Helena and Isabel share an interview with GOLD’s new catalyst John Wahba, Medical Head of the Global Digital Hub, GS
World AIDS Day 2022 special
Helena and Isabel share a very special episode to mark World AIDS Day, featuring Dr Nneka Nwokolo, Global Head of Patient Affairs at ViiV.
Loading posts...
« Previous
1
…
5
6
7
8
9
…
23
Next »